| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 28.476 | 337.373 | 534.194 | 739.070 | 564.509 | 790.756 | 960.657 | 856.180 | 1.017.862 |
| Total Income - EUR | - | 28.596 | 340.948 | 542.722 | 746.553 | 590.155 | 800.065 | 1.000.470 | 875.020 | 1.030.475 |
| Total Expenses - EUR | - | 99.432 | 499.435 | 671.002 | 774.033 | 565.759 | 716.898 | 930.113 | 939.010 | 1.179.255 |
| Gross Profit/Loss - EUR | - | -70.835 | -158.487 | -128.280 | -27.480 | 24.396 | 83.167 | 70.357 | -63.990 | -148.780 |
| Net Profit/Loss - EUR | - | -71.120 | -165.708 | -133.625 | -31.925 | 20.286 | 69.532 | 60.169 | -68.856 | -150.185 |
| Employees | - | 2 | 10 | 11 | 11 | 8 | 7 | 8 | 8 | 9 |
Check the financial reports for the company - Isispharma Derma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 7.782 | 5.538 | 5.855 | 4.140 | 2.761 | 1.971 | 1.317 | 941 | 2.274 |
| Current Assets | - | 109.539 | 284.452 | 429.465 | 546.228 | 722.608 | 933.772 | 815.911 | 877.009 | 756.738 |
| Inventories | - | 63.126 | 92.947 | 125.874 | 65.390 | 105.945 | 165.920 | 170.462 | 196.184 | 178.536 |
| Receivables | - | 36.264 | 189.916 | 278.256 | 470.698 | 611.958 | 648.819 | 437.272 | 607.801 | 429.296 |
| Cash | - | 10.149 | 1.589 | 25.334 | 10.141 | 4.706 | 119.033 | 208.177 | 73.024 | 148.906 |
| Shareholders Funds | - | -61.100 | -225.774 | -355.255 | -380.301 | -352.806 | -275.449 | -216.135 | -284.336 | -432.931 |
| Social Capital | - | 10.020 | 9.851 | 9.670 | 9.483 | 9.303 | 9.097 | 9.125 | 9.097 | 9.046 |
| Debts | - | 179.187 | 516.708 | 791.114 | 931.626 | 1.078.744 | 1.211.492 | 1.033.724 | 1.162.651 | 1.193.869 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 311 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4645 - 4645" | |||||||||
| CAEN Financial Year |
4645
|
|||||||||
Comments - Isispharma Derma Srl